|
Comparisons of NT-proBNP levels according to the occurrence of cardiac dysfunctions during the intensive care unit course |
||||
| RVD (n = 17) |
LVSD (n = 18) |
LVDD (n = 18) |
NCD (n = 11) |
|
|
|
||||
| NT-proBNP in pg/ml on day 1 |
6,138 (3,530–16,458) |
6,214 (3,721–30,409) |
9,001 (4,000–33,167) |
4,220 (488–17,371) |
| NT-proBNP in pg/ml on day 2 |
7,685 (3,965–23,433)a |
9,083 (3,860–22,784)a |
11,254 (4,067–37,804)a |
914 (447–12,545) |
|
ap < 0.05 compared to the no cardiac dysfunction (NCD) group. Data are expressed as median (25th–75th percentiles). The number of patients in whom NT-proBNP was measured on day 2 was the same as on day 1 (no death on day 1). LVDD, left ventricular diastolic dysfunction; LVSD, left ventricular systolic dysfunction; NT-proBNP, N-terminal pro-brain natriuretic peptide; RVD, right ventricular dysfunction. | ||||
Mokart et al. Critical Care 2007 11:R37 doi:10.1186/cc5721 |
||||